SearchDictionaryMobileLogin

SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (MPP+)-induced cytotoxicity via the downregulation of ROS generation and JNK signaling.

AbstractSensitive to apoptosis gene (SAG), a novel zinc RING finger protein, exhibits anti-apoptotic and antioxidant activity against a variety of redox reagents. In the present study, we have determined that SAG suppresses 1-methyl-4-phenylpyridinium ion (MPP(+))-induced neurotoxicity via the downregulation of ROS generation and c-Jun N-terminal kinase 1 (JNK1) activity. Both transient and constitutively overexpressed SAG were found to inhibit the MPP(+)-induced neurotoxicity of SH-SY5Y neuroblastoma cells. In the SAG-expressing cells, MPP(+) induced ROS generation was suppressed to a significant degree as compared to the cells treated only with MPP(+). MPP(+)-induced JNK1 activation was also determined to be suppressed markedly by SAG. Furthermore, SAG inhibits MEKK1 dependent c-Jun transcription activity in SH-SY5Y cells. Thus, we concluded that SAG is a cellular protective molecule, which appears to function as an antioxidant, suppressing MPP(+)-induced neurotoxicity.
AuthorsSun-Yee Kim, Mi-Yeon Kim, Jung-Soon Mo, Jeen-Woo Park, Hee-Sae Park (Affiliation: Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Yongbong-dong, Buk-ku, Gwangju 500-757, Republic of Korea.)
JournalNeuroscience letters (Neurosci Lett) Vol. 413 Issue 2 Pg. 132-6 (Feb 14 2007) ISSN: 0304-3940 Ireland
PMID17240529 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Neurotoxins
  • RNA-Binding Proteins
  • RNF7 protein, human
  • Reactive Oxygen Species
  • 1-Methyl-4-phenylpyridinium
  • JNK Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinase 1
  • MAP3K1 protein, human
  • Ubiquitin-Protein Ligases
Topics
  • 1-Methyl-4-phenylpyridinium (toxicity)
  • Animals
  • Antioxidants (metabolism)
  • Cell Line, Tumor
  • Cell Survival (drug effects, genetics)
  • Enzyme Activation (drug effects, genetics)
  • Gene Expression Regulation (genetics)
  • Humans
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • MAP Kinase Kinase Kinase 1 (metabolism)
  • Mice
  • NIH 3T3 Cells
  • Neuroblastoma
  • Neurons (drug effects, metabolism, pathology)
  • Neurotoxins (toxicity)
  • Oxidative Stress (drug effects, genetics)
  • Parkinson Disease (genetics, physiopathology, therapy)
  • RNA-Binding Proteins (genetics)
  • Reactive Oxygen Species (metabolism)
  • Ubiquitin-Protein Ligases